Glenmark Pharma to divest 75% stake in life sciences unit for $680m

Glenmark Pharmaceuticals has signed a definitive agreement for the divestiture of a 75% stake in Glenmark Life Sciences for $679.85m.

Sep 23, 2023 - 20:00

Glenmark Pharma to divest 75% stake in life sciences unit for $680m

Glenmark Pharmaceuticals has signed a definitive agreement for the divestiture of a 75% stake in Glenmark Life Sciences for $679.85m.

Read the original article

Tags:

Previous Article

Novo Holdings acquires biopharma company Paratek for $462m

Debiopharm, SunRock sign agreement for cancer ADCs

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: ‘It’s like Groundhog Day’: The cancer drug shortage isn’t new — and neither are the solutions

STAT+: ‘It’s like Groundhog Day’: The cancer drug short...

Jun 28, 2023

‘I don’t see this as an end to the pandemic’: Ashish Jha on the end of Covid public health emergency

‘I don’t see this as an end to the pandemic’: Ashish Jh...

May 11, 2023

GLB-001 by GluBio Therapeutics for Relapsed Acute Myelo...

Dec 20, 2023